Find your path to Martin
648 people in our graph share verified history with Martin — schools, employers, funds. One of them is your warm intro.
About
Martin Birk is a fractional CFO/COO with over 16 years of experience in life sciences, medtech, and regulated startups, currently serving as CFO at SpiroChem. His work covers strategic finance and cash planning, fundraising and investor reporting, public grants including Innosuisse, SNF, and EU programs, and the application of generative AI to finance and operational workflows. He is co-founder, CEO, and board member of TransHeps AG, which focuses on DILI diagnostics and liver cell models, and a founding member of the Boardy Pro Advisory Board.
CFO at Resistell
Intro paths
In turn, Martin can intro founders to Resistell's investors below.
Resistell's investors · 3
Co-founders at Resistell

Experience
- SpiroChemCFOcurrent2025 — presentBasel, Switzerland
- ResistellFractional CFOcurrent2023 — presentMuttenz, Basel-Country, Switzerland
- TransHepsCo-Founder, CEO & Board Membercurrent2024 — presentZurich, Switzerland
- TransHepsCFO/COO2024Zurich, Switzerland
- BoardyFounding Member, Boardy Pro Advisory Boardcurrent2026 — present
- BoardyDeal Partnercurrent2026 — presentZurich, Switzerland
- InSpheroInterim CFO2022 — 2023Schlieren, Zurich, Switzerland
- InSpheroHead of Finance & Controlling (IT, Legal)2018 — 2022Schlieren, Kanton Zürich, Schweiz
- Manor AGHead of Management Reporting2017 — 2018Basel, Basel, Switzerland
- LonzaManager - Corporate Controlling2014 — 2016Basel, Basel, Switzerland
- CoopInternal Audit Manager2013 — 2014Basel
- LonzaSenior Auditor2011 — 2013Basel
- BayerBusiness Auditor2008 — 2011Leverkusen
Skills & more
+12 more
Digital TransformationLifesciencesFinanceBusiness StrategyAuditingInternal AuditInternal ControlsFinancial AnalysisProject ManagementDue DiligenceFinancial ReportingFinancial AuditsLanguages English · French · German · Spanish
- Chief Operating Officer (COO) Program — Emeritus
- Supply Chain Management: Leading with AI and Digital Transformation — Emeritus
- Designing and Building AI Products and Services — Emeritus
- Psychologie des Verhandelns und des Überzeugens — LinkedIn
- Balanced Scorecard and Key Performance Indicators — LinkedIn
- Running a Profitable Business: Understanding Financial Ratios — LinkedIn
From Martin's professional profile.
Frequently asked questions
- Who is Martin Birk?
- Martin Birk is a fractional CFO/COO with over 16 years of experience in life sciences, medtech, and regulated startups, currently serving as CFO at SpiroChem. His work covers strategic finance and cash planning, fundraising and investor reporting, public grants including Innosuisse, SNF, and EU programs, and the application of generative AI to finance and operational workflows. He is co-founder, CEO, and board member of TransHeps AG, which focuses on DILI diagnostics and liver cell models, and a founding member of the Boardy Pro Advisory Board.
- Where does Martin Birk work?
- Martin Birk is CFO at Resistell.
- Where did Martin Birk go to school?
- Martin Birk studied at Massachusetts Institute of Technology (Chief Operating Officer Program, Strategy); University of Louisville (Master's degree, Industrial Engineering); Justus Liebig University Giessen (MSc, Biochemistry).
Same school
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Also attended ESCP491
+ 485 more
Also attended The Open University105
+ 99 more
Also attended The University of Freiburg76
+ 70 more
Shared employers
Also worked at Resistell3
Also worked at Boardy45
+ 39 more
Also worked at Manor AG2
Also worked at Bayer148
+ 142 more















































